BW CAPITAL (PHARMA) LIMITED

🌱Startupactive
15900962 · ltd · incorporated 2024-08-16
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
🔒Estimated value
Upgrade to see
Turnover
year to Aug 2025
Net worth
£-200
book net assets
Opportunity
75/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Other activities auxiliary to financial services, except insurance and pension funding
Sector: Financial & insurance
Investor take
Pass (distressed without resilience)
Distressed active trading company — structural issues outweigh the discount.

Opportunity 75/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: medium (71/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
1 year of iXBRL accounts extracted (no YoY comparison) + narrative notes parsed
50
Lenders & charges
Confirmed no charges registered
85
Directors & officers
2 officers (2 active, 2 linked, 2 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
2 connected companies via shared directors
51
Filing history
5 filings
60
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
75/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
60
Adequate — check latest filings for context.
Acquirability
75
Strong succession / seller-readiness signals.
Risk profile
82
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 105 (micro)
Negative net assets
Liabilities exceed assets by £200

Key financials

1 year extracted from filed iXBRL accounts
Cash
Net Worth
-£200
Current Assets
£100
Current Liabilities

Financials

Extracted from Companies House accounts · FRS 105 (micro)
Metric2025-08-31
Total assets£-300
Current assets£100
Net assets£-200

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
1
filing
  • 1 accounts
Last 180 days
1
filing
  • 1 accounts
Counts from Companies House filing history.
Corporate timeline (7 events)Click to expand
  1. 2026-03-02
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  2. 2025-07-25
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  3. 2025-07-09
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  4. 2024-08-16
    🏢
    Company incorporated
    As BW CAPITAL (PHARMA) LIMITED
  5. 2024-08-16
    BHAKAR, Balvinder appointed
    director
  6. 2024-08-16
    WEBSTER, Michael Anthony appointed
    director
  7. 2024-08-16
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

71/100
High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS
  • +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
  • +Senior director age: Director aged approximately 62 — approaching natural succession window.
  • +Young company: Only 1.8 years old — management layer unlikely to be developed.

Succession & seller-readiness

46/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • secondaryFounder aged 58+: Senior director is approximately 62. Early succession window.
  • secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.

Red flags

1 low
Multiple registered office changes
low

Multiple address changes in a short period can indicate operational instability or admin disorder.

Group structure

Bw Capital Group Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.

🏛️
Bw Capital Group Limited
Corporate parent · holds 75-100% shares · board control
ultimate parent
BW CAPITAL (PHARMA) LIMITED
This company · 15900962

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Bw Capital Group Limited
Corporate entity
75100%
75–100%board control75-100% shares · 75-100% voting · board control16/08/2024

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Financial services · CB postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
16PHD LTD
16581590 · est 2025 · no financials extracted
ABBEXA CAPITAL LTD
12129610 · est 2019 · no financials extracted
6y
ACCELERATOR ADVISORY LIMITED
12144298 · est 2019 · no financials extracted
6y
ANABER INVESTMENTS LTD
15929869 · est 2024 · no financials extracted
1y
ASE INTERNATIONAL LTD
11841295 · est 2019 · no financials extracted
7y
BARTON LILY
15111720 · est 2023 · no financials extracted
2y
BEST ADVICE INVESTMENTS LIMITED
02357150 · est 1989 · no financials extracted
37y
BLOOMTECH BUSINESS SERVICES LIMITED
15767231 · est 2024 · no financials extracted
1y
BLUE AND GOLD INVESTMENTS LTD
16373441 · est 2025 · no financials extracted
1y
BONMARK PROPERTIES LIMITED
02177734 · est 1987 · no financials extracted
38y
BRIGHT FUTURE FINANCE LIMITED
05248953 · est 2004 · no financials extracted
21y
CAMBRIDGE AGRITECH CAPITAL LIMITED
12181480 · est 2019 · no financials extracted
6y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2024-08-16
Jurisdictionengland-wales
Primary SIC66190 — Other activities auxiliary to financial services, except insurance and pension funding

Registered office

6c Camps Road
Haverhill
CB9 8HB
England

Filing status

Accounts
Next due: 2027-05-31
Last made up to: 2025-08-31
Confirmation statement
Next due: 2026-08-29
Last: 2025-08-15

Officers (2 active · 0 resigned)

BHAKAR, Balvinder
director · ~51y · appointed 2024-08-16
View their other companies + combined net worth →
Active
WEBSTER, Michael Anthony
director · ~62y · appointed 2024-08-16
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (5 total)

accounts-with-accounts-type-micro-entity
accounts · AA
2026-03-02
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-08-26
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2025-07-25
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2025-07-09
incorporation-company
incorporation · NEWINC
2024-08-16